STAT
JUNE 29, 2024
The Food and Drug Administration’s power to make important regulatory decisions is in question after a Supreme Court decision weakening agencies ’ ability to interpret ambiguous statutory measures. The ruling could mean headaches not just for the teams of lawyers and scientists at the FDA, but for the drug and device companies the agency is charged with regulating.
Drug Patent Watch
JUNE 29, 2024
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […] Source
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 29, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
EMCrit Project
JUNE 29, 2024
Necrotizing Fasciitis and NSTI EMCrit Project by Scott Weingart, MD FCCM.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Drug Patent Watch
JUNE 29, 2024
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JUNE 29, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
PharmaTech
JUNE 29, 2024
This acquisition will give AbbVie acces to Celsius Therapeutics' lead drug candidate, CEL383, a potential first-in-class anti-TREM1 antibody for treating IBD.
pharmacy mentor
JUNE 29, 2024
This Case Study literally blew our minds, and it still does. Dive into how we helped this private DSP go from literally no online presence to making over £120,000 per month, in the space of five months (and they’re growing daily) About This Pharmacy This Private DSP, consisting of Independent Prescribers (IPs), began their journey with us in November 2023.
PharmaTech
JUNE 29, 2024
The seven chosen sponsors will help accelerate development of novel drugs and biologics for rare diseases.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaState Academy
JUNE 29, 2024
Thank you for your registration! Next Step > Join the WhatsApp group for quick updates. Join WhatsApp Group We will send you the live session Zoom link & other details in your Email. Join WhatsApp Group Happy Learning!
Pharmacy Times
JUNE 29, 2024
The European Union (EU) has successfully created a competitive market for biosimilars, while the US faces challenging market dynamics and tactics by pharmacy benefit managers that hinder the adoption of lower-cost therapies.
Express Pharma
JUNE 29, 2024
Menopause is usually diagnosed clinically when a woman hasn’t menstruated for a year due to a decline in ovarian follicular activity. This condition can generally occur around 45–55 years of age. In India, there are approximately 150 million women experiencing menopause, as per data shared by the Indian Menopause Society (IMS). The average age of menopause in the country is 46.2 years, as compared to the global average of 51 years.
Expert insights. Personalized for you.
359 
Let's personalize your content